SomnoMed® is a leading medical device company in the treatment of patients suffering from Obstructive Sleep Apnoea (OSA) and adjacent conditions. Founded in 2004, headquartered in Sydney and now operating in over 28 countries with 4 dedicated labs in Europe. Our mission is to advance the adoption, acceptance and treatment of oral sleep apnoea therapies by medical specialists, dentists, patients, insurers and other stakeholders. More than 800,000 patients around the world with mild and moderate OSA have been successfully treated with our oral appliances. SomnoMed® realises that no two patients are alike, which is why we are delivering the SomnoDent® family of devices, with a wide array of options to treat your Obstructive Sleep Apnoea patients. Our products are 510(k) cleared by the FDA (Food and Drug Administration, US) and manufactured in accordance with ISO 13485 quality standards and MDR (EU) 2017/745.
